| Carole L Most, MD | |
|
9400 Rosecrans Ave, Bellflower, CA 90706-2246 | |
| (562) 461-3000 | |
| Not Available |
| Full Name | Carole L Most |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Hematology & Oncology |
| Location | 9400 Rosecrans Ave, Bellflower, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306985007 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | A46243 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Carole L Most, MD 9400 Rosecrans Ave, Bellflower, CA 90706-2246 Ph: (562) 461-3000 | Carole L Most, MD 9400 Rosecrans Ave, Bellflower, CA 90706-2246 Ph: (562) 461-3000 |
News Archive
athenahealth, Inc., a leading provider of cloud-based business services for physician practices, today announced that OhioHealth, a family of not-for-profit hospitals and healthcare organizations consisting of more than 900 physicians serving patients throughout a 40-county area in Ohio since 1891, has selected athenaCommunicator, athenahealth's patient communication service.
A new review provides guidance on a deadly, but rare, disease that is potentially curable if identified early. Severe combined immunodeficiency disease (SCID), known as the "bubble boy disease" in the 1970s, is treatable with a stem cell transplant, gene therapy and other treatments if identified at birth or soon after.
Among overweight adults, participation in an intensive lifestyle intervention (that included counseling sessions and targets to reduce caloric intake and increase physical activity) was associated with a greater likelihood of partial remission of type 2 diabetes, however the absolute remission rates were modest, according to a study in the December 19 issue of JAMA.
In ruling on the constitutionality of requiring most Americans to obtain health insurance, the Supreme Court faces a central test: whether it will recognize limits on its own authority to overturn well-founded acts of Congress.
The National Institutes of Health has launched three innovative projects that will focus on development of therapeutics for Fragile X syndrome, nicotine addiction, and age-related macular degeneration. These projects are funded through the NIH Blueprint Neurotherapeutics Network which provides access to a variety of drug development resources.
› Verified 6 days ago
Basil Z. Abdelkarim, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 9400 Rosecrans Ave, Bellflower, CA 90706 Phone: 562-461-3000 | |
Darren K. Shimabukuro, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 9400 Rosecrans Ave, Bellflower, CA 90706 Phone: 562-461-3000 | |
Jennifer T. Nguyen, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 9400 Rosecrans Ave, Bellflower, CA 90706 Phone: 562-461-3000 | |
Dr. Ana Franco Borgas, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 9400 Rosecrans Ave, Module 3200, Bellflower, CA 90706 Phone: 562-461-4033 Fax: 562-461-4047 | |
Laurie A. Chu, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 9400 Rosecrans Ave, Bellflower, CA 90706 Phone: 562-461-3000 | |
Edward H. Wang, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 9400 Rosecrans Ave, Bellflower, CA 90706 Phone: 562-461-3000 | |
Earl Bautista, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 9400 Rosecrans Ave, Bellflower, CA 90706 Phone: 562-461-3000 |